key: cord-0869005-57k9jmzq
authors: Fazolo, T.; Lima, K.; Fontoura, J. C.; Souza, P. O. d.; Hilario, G.; Zorzetto, R.; Rodrigues, L.; Pscheidt, V. M.; Ferreira Neto, J.; Haubert, A. F.; Gambin, I.; Oliveira, A. C.; Mello, R. S.; Gutierrez, M.; Gassen, R. B.; Sauthier Sartor, I. T.; Zavaglia, G. O.; Fernandes, I. R.; Varela, F. H.; Polese-Bonatto, M.; Borges, T. J.; Callegari-Jacques, S. M.; da Costa, M. S. C.; Schwartz, J. d. A.; Scotta, M. C.; Stein, R. T.; Bonorino, C.
title: Strong anti-viral responses in pediatric COVID-19 patients in South Brazil
date: 2021-04-16
journal: nan
DOI: 10.1101/2021.04.13.21255139
sha: 8b3e07a8fe2046ef6beb84e117be0667661d0ec3
doc_id: 869005
cord_uid: 57k9jmzq

Epidemiological evidence that COVID-19 manifests as a milder disease in children compared to adults has been reported by numerous studies, but the mechanisms underlying this phenomenon have not been characterized. It is still unclear how frequently children get infected, and/or generate immune responses to SARS-CoV-2. We have performed immune profiling of pediatric and adult COVID-19 patients in Brazil, producing over 38 thousand data points, asking if cellular or humoral immune responses could help explain milder disease in children. In this study, pediatric COVID-19 patients presented high viral titers. Though their non-specific immune profile was dominated by naive, non-activated lymphocytes, their dendritic cells expressed high levels of HLA-DR and were low in CX3CR1, indicating competence to generate immune responses that are not targeted to inflamed tissue. Finally, children formed strong specific antibody and T cell responses for viral structural proteins. Children s T cell responses differed from adults in that their CD8+ TNF+ T cell responses were low for S peptide but significantly higher against N and M peptide pools. Altogether, our data support a scenario in which SARS-CoV-2 infected children may contribute to transmission, though generating strong and differential responses to the virus that might associate with protection in pediatric COVID-19 presentation.

COVID-19 is a complex disease, with multisystemic involvement, and an array of clinical manifestations that can vary from asymptomatic to severe outcomes leading to death (1) which lead to an ongoing worldwide emergency (2) . Epidemiological evidence of less severe forms of the disease and reduced mortality in children upon infection with SARS-CoV-2 has been consistently reported (3, 4) , except for an inflammatory syndrome (MISC) associated with comorbidities in a relatively low percentage of children (5) . The pediatric population (0-19 years old) represents more than 25% of the Brazilian population, however, it is observed that this group corresponds to only 1.9% (19,589 / 989,170) of all cases of SARS by reported in the past 12 months. Mortality among children represented 0.5% (1,564 / 321,659) of all deaths due to the disease reported in the same period. The lethality in children and adolescents hospitalized due to SARS by covid-19 was 8.0% (1,574 / 19,589) , while the overall lethality in all age groups was 32.5% (321,659 / 989,170), in the observed period (data from SIVEP-Gripe, Ministry of Health). Thus, a significantly lower number of children and adolescents has severe clinical presentations with the need for hospitalization, or that will lead to death, when compared to other age groups.

Different hypotheses have been raised to explain this phenomenon (6, 7) . Milder disease in children could result from a reduced expression of the viral receptor ACE2, leading to lower levels of viral replication (8). Alternatively, it could be explained by a differential immune response in children, correlated to a distinct infection course from adults (9). A third popular hypothesis is that the pre-existence of neutralizing antibodies to seasonal coronaviruses could confer some cross-protection against SARS-CoV-2 induced disease, mainly because children are considered the main reservoir for these viruses (10) . At present, the scarcity of data prevents . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ;  https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint a clear understanding of the striking differences between the pediatric and adult outcomes after infection by Comprehensive studies have characterized immune responses in adults with mild or severe forms of COVID-19 (11) (12) (13) (14) . However, considerably fewer studies have focused on pediatric patients. This is a subject of paramount importance, not only because it is central to the design of public policies regulating school opening (and all the activities associated with it) during the pandemic, but also because understanding the milder disease presentation in children may provide important clues for the design of prevention strategies as well as novel therapeutic pathways for the management of COVID-19. In this study, we sought to characterize in detail the innate and adaptive immune responses in a cohort of patients consisting of adults with different degrees of severity and children with mild disease presenting at health care facilities with symptoms suggestive of COVID-19. We sought to identify an immune profile in children that could explain the striking differences in outcome between them and adult COVID-19 patients. We collected plasma and peripheral blood mononuclear cells (PBMCs) from adult and pediatric COVID-19 patients, and detailed characterization of their immune response was performed by multi-parameter flow cytometry, defining 78 immune cell subsets and expression of key activation markers, anti-SARS-CoV-2 IgA and IgG antibodies, and frequencies of specific effector T cells, producing 38,670 data points. Pediatric patients with mild COVID-19 had high viral load titers, high frequencies of dendritic cells, with high HLA-DR expression, but low in CX3CR1. Although their non-specific adaptive cells immune profile was dominated by antigen-inexperienced cells, SARS-CoV-2 specific antibodies and T cells were detected in levels comparable to the ones in adults with either severe or mild disease. Children showed higher CD8+ TNF+ T cell responses to N and M peptide pools than for S peptides, while this was not observed in adults. This response did not correlate with anti-S or anti-N antibody levels. Taken together, our findings suggest that children produce a differential immune . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 16, 2021 In vitro T cells stimulation assays PBMC were thawed, assayed for viability, counted, and plated in 96-well plates at 3×10 6 PBMCs/mL, 100 uL/well in RPMI1640 medium (Sigma-Aldrich -R8758) supplemented with . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint 10% fetal bovine serum (100 IU of penicillin/mL, 100 μg of streptomycin/mL (Lonza, Belgium) and 2 mM L-glutamine (Lonza, Belgium) (R10H medium), and subsequently stimulated with peptide PepTivator SARS-CoV-2 Prot S (130-126-700 -Miltenyi Biotec, Germany), PepTivator SARS-CoV-2 Prot N (130-126-698 -Miltenyi Biotec, Germany) and

PepTivator SARS-CoV-2 Prot M (130-126-702 -Miltenyi Biotec, Germany) at 1 μg/mL. PMA (50 ng/mL, Sigma, USA) plus ionomycin (1 μg/mL, Cayman chemical company, USA) and DMSO were used as positive and negative controls for stimulation, respectively. Stimulation with a CMV peptide pool at 2μg/mL (Mabtech, Sweden) was also performed, as a positive control for the assay. All treatments were submitted for 18h at 37ºC and 5% CO2. Three hours before harvesting, Golgi Plug (BD Biosciences, USA) 1μg/mL was added to each well. Cells were stained and analyzed for phenotype as described above.

Plasma was tested for IgG and IgA antibodies to S-RBD protein (#RP-87678 -Invitrogen, USA) and N protein (kindly provided by Dr. Ricardo Gazinelli -Fiocruz Belo Horizonte, Brazil) using a protocol described in (16) . Briefly, ELISA plates (Kasvi, Brazil) were coated overnight with 1μg/mL of SARS-CoV-2 Spike Protein (S-RBD). On the following day, plates were blocked for 1 h at room temperature with blocking buffer (3% Skim Milk Powder in Phosphate Buffered Saline (PBS) containing 0.05% Tween-20). Plasma samples were heatinactivated at 56°C for 60 minutes and then serially diluted in 1% milk in 0.05% PBS-Tween 20 starting at a 1:25. Plasma was incubated for 2 h at 37°C. Secondary antibodies were diluted in 0.05% PBS-Tween and incubated for 1 h at room temperature. For both IgG, anti-human peroxidase produced in rabbit (#IC-1H01 -Rhea Biotec, Brazil), and IgA, anti-human peroxidase produced in goat (#A18781 -Invitrogen, USA), was used at a 1:10,000 dilution.

The assay was developed with TMB Elisa Substrate -High Sensitivity (Abcam, United . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

The study design is summarized in Figure 1A . We have recruited a total of 92 patients (25 children; 34 adults with mild disease -AMD; and 33 adults with severe disease -ASD). All . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint subjects had COVID-19 confirmed by PCR. All children had mild disease and were treated as outpatients. Their characteristics are described in Table 1 . Patients' characteristics and mean cycle threshold (Ct) values are displayed in Table 1 . As expected, comorbidities were concentrated in the group with severe disease, which was also the group with a higher mean age. Some symptoms are probably not accurately assessed in some children, such as anosmia or dysgeusia, due to the age of some individuals in this group. Median Ct levels for all three probes used in PCR were higher in AMD, and not different between ASD and children. Figure 1B ). 3D plotting performed to include PC3 showed that children again separated from mild and severe adult patients ( Figure 1C ) and confirmed in 2D ( Figure 1D ). The PC scores from all three groups were plotted and the significance of these differences was analyzed by a Kruskal-Wallis (KW) test. Children had the highest mean score value for PC1 (2.765), followed by AMD (0.142) and ASD (-2.351), and these differences were highly significant ( Figure 1E ). For PC2, AMD had a mean score of 2.079, higher (p<0.0001) from children and ASD (mean scores of -1.585 and -1.180, respectively, p>0.999). PC3 scores were highest in . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. Figure   2B ) influencers, variables for PC1, PC2, and PC3. The comparison of the three groups for their . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint variances regarding each variable agreed with the differences among them detected by PCA.

A pattern that emerged from these two combined analyses was that children, AMD and ASD, separate from each other based mostly on differences in targeting innate inflammatory responses to inflamed tissues, and the state of activation of B and T lymphocytes.

The percent of the total variability explained by these first principal components was low; the first three PCs together explained only 28.81% of the variance (Supplementary Table 1 ). This indicated that these 78 variables were not highly correlated as a whole. A correlation analysis using Spearman´s coefficient confirmed this observation (Supplementary Figure 2) , revealing a general pattern of moderate to weak correlations, but also identifying clusters of variables that were more correlated than others. These clusters represented six types of immune Figure   3A ) and NK cells ( Figure 3B ), although derived from expressive correlations among their respective variables, did not separate the three groups of patients, indicating that the individuals were not significantly different for the variables that composed these PCs. That was intriguing because those variables had, as stated above, important contributions for the PC2 of all . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint variables ( Figure 1 ), but it also indicated that this contribution helped separate the groups mostly based on their correlations with other variables in the group of all variables, and not on the differences among groups for those variables alone. Although highly correlated among them (Supplementary Figure 2) , variables composing the signatures for Granulocytes + Monocytes and NK cells did not separate the groups when used together in a PCA (not shown) and did not generate any new information.

Findings in PCA for the DCs signature ( Figure 3C ) indicated that children were significantly separated from ASD, but not from AMD, with lower scores for PC1 (mostly CX3CR1 expression in DCs) and higher scores for frequencies of DCs ( Figure 3C ). HLA-DR expression in DCs subpopulations constituted negative contributions for PC1. This indicated that children, as well as AMD, would have more DCs than ASD, high in HLA-DR and low in CX3CR1. That was confirmed by the KW analysis of the three groups ( Figure 3C ). Spearman correlation analysis ( Figure 3D ) evidenced that CX3CR1 expression was negatively correlated with HLA-DR expression. These results suggested that high DCs frequencies in blood, with low CX3CR1, but high HLA-DR expression could be involved, or at least serve as markers, for mild disease.

Inversely, low DCs frequencies, with high CX3CR1 expression, could be associated with more severe disease. Figure 6 shows the responses compared among the groups. About 30% of individualsof all groupsdid not show responding CD4+ T cells to the peptide pools; a higher frequency of individuals did not respond to the S pool compared to the M and N pools. In the ones that responded, CD4+ IL-17+ T cell responses were higher for all three peptide pools (about 1 log higher than INF and TNF CD4+T cell responses). CD8+ T cell responses were, in general, more robust, although for S and M peptide pools there were still some individuals, though fewer, that did not respond to stimulation. The absence of response, in our sample, did not correlate with the early time of collection, as reported by (18). TNF+ CD8+ T cell responses were about 1 log higher than what was detected for CD4+ T cells, for all peptide pools (Supplementary Figure   6 ). The IL-17+ CD4+T cells responses to stimulation by all three pools, were higher than the TNF+CD4+ and INF+ CD4+ for all three groups. The differential TNF+ cytotoxic response to M and N peptides seen in children led us to investigate levels of anti-N antibodies.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint Children made strong anti-N IgG levels, not different from AMD and ASD ( Figure 6A ). Anti-RBD IgA, but not IgG levels, correlated positively with CD4+ INF+ responses ( Figure 6B ).

Interestingly, the TNF+ cytotoxic responses to M and N peptide pools were inversely correlated with levels of anti-RBD and anti-N antibodies ( Figure 6B ). Anti-N antibody levels correlated positively with anti-N CD4+INF+ responses ( Figure 6B ). Taken together, these results indicate that children do generate specific humoral and effector cell responses upon infection with SARS-CoV-2, with a differential, higher cytotoxic response against proteins M and N, not associated with antibody responses to the spike protein.

It is clear from our study as well as from others (23) (25), and should be more carefully studied, given its importance for planning school openings. Our findings on the more naïve, non-specific lymphocyte profile presented by in children, if taken isolated from the other results in this study, could indicate that a naive immune system does better than an old one, as has been suggested (9)that children would be better equipped to mount fast and efficient immune responses to rapidly clear the virus. However, one prediction from this hypothesis is that children would be more likely to present mild forms of all viral diseases, and this is not the case. While milder manifestations are observed in MERS, SARS, and varicella, the opposite is observed for infection with poliovirus, and also respiratory viruses, especially influenza and respiratory syncytial virus (RSV) -reviewed in (6) .

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint

Our data indicate the possibility that not only the adaptive but also their innate immune system has relevant characteristics that enabled children to mount an efficient immune response and control the infection. The important differences observed for dendritic cells might offer an important clue. DCs play crucial roles in initiating and shaping the adaptive response, and subpopulations of DCs, especially pDC, are determinants for the generation of efficient antiviral responses, being one of the main sources of type I interferon (26). A previous study in COVID-19 adult patients indicated decreased activation and numbers of DCs (27). In our study, children consistently showed higher frequencies of DCs, including pDCs, compared to adults. High HLA-DR expression is characteristic of mature DCs; as they become activated by engagement of pattern recognizing receptors, HLA-DR first increases, and then decreases as DCs migrate to draining lymph nodes (26,28) Low HLA-DR expression in children is associated with immune suppression (4) and acute inflammatory conditions (29) . The inverse correlation of HLA-DR with CX3CR1 in DCs is intriguing. CX3CR1, also known as the fractalkine receptor, is considered a homing marker for inflamed tissue and plays a role in pathology in Japanese virus-induced encephalitis ref (30) and peritoneal vasculitis in a sepsis model (31) . The high levels of HLA-DR in children's DCs indicate that their cells are not poorly activated, but mature and able to generate efficient immune responses. The low expression of CX3CR1 suggests that children's DCs are not targeted to inflamed sites, as they seem to be in ASD. Our results indicate that expression of CX3CR1 in circulating DCs could associate, or serve as a marker for, pathological mechanisms in severe COVID-19, and suggest that inflammation to specific sites such as the lung may be affected by age.

Pediatric patients in our sample presented SARS-CoV-2-specific antibodies and T cell responses in levels comparable to adult patients. Based on our data, we propose that the higher CD8+TNF+ responses for the M and N proteins could be associated with a protective response in children. The M protein is the most abundant structural protein on the surface of . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Children are considered the natural reservoir of seasonal coronaviruses that cause the common cold (4) . A hypothesis frequently raised to explain milder disease in children with is that the presence of neutralizing antibodies to such viruses could cross-protect them upon . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint infection with SARS-CoV-2. However, a recent study in adults found no evidence of crossprotection associated with levels of these antibodies (38). Alternatively, protection could be conferred not by cross-reactive antibodies, but rather by pre-existing N-protein-specific T cells. indicated that T cell immunity to SARS-CoV-2 infected individuals includes many targets outside the spike protein and that they are not conserved among coronaviruses that cause the common cold. These findings are in agreement with the ones of the Le Bert study. Our results support that the role of T cell responses to the N protein must be further investigated, with a more detailed T cell epitope mapping. Such work might reveal additional correlates of protection, and/or epitopes to add in the next generation of COVID-19 vaccines. A recent report (39) indicated that T cell immunity was not markedly affected, so far, by the emergence of new variants, supporting the study of T cell epitopes to be added to the next vaccines.

The main limitation of this study is that it is mostly an exploratory, descriptive one, and compares individuals in different age groups. We believe this was a valid approach given the magnitude of what is unknown at the moment. Usually, biomarkers in peripheral blood are only useful when highly correlated with outcomes. Yet, most studies that seek to understand how immune responses can correlate with protection compare adult s with mild and severe disease, and it is known that these are in different age groups. At present, the best age-matched controls for SARS-CoV-2 infected patients are still unknown. Certainly, the absence of a prepandemic healthy children control group is a limitation of this and all the other studies that focused on the general, non-specific immune profile of children with COVID-19. There is still much to be understood about immunological differences not only between pediatric and adult COVID-19 patients but also in other diseases. In this sense, we believe our work contributes significant information which was collected in a completely unbiased investigation -we did . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint not know what differences or similarities to expect. At the time the project started, COVID-19 numbers in Brazil were still not high and the frequency of MISC patients or children with severe manifestations of the disease was still too low to include. Inclusion of patients was easiest in ASD because they were admitted to the hospital, thus their time of symptoms to sample collection is shorter compared to AMD and children. However, we do not think this was a major influence in the results -if so, differences would have been highest between ASD and AMD, and that was not the case. Finally, these results are based on a single point of collection and we still do not know how they will evolve into the memory responses that will be ultimately generated. The study on this cohort is still ongoing, with two more points of sample collection. We expect that further analysis of our data, as well as other studies', on immune profile data and specific responses, will bring relevant information on the generation of immune memory in pediatric COVID-19.

Funding for this study was provided by PROADI -HMV, and the Ministry of Health; fellowships for Karina Lima, Julia Fontoura, Renato Stein, and Cristina Bonorino are from CNPq; fellowships for Gabriel Hilario, Priscila Oliveira, and Tiago Fazolo are from CAPES.

TJB is a recipient of an American Heart Association fellowship grant. We wish to thank Drs.

André Báfica, Daniel Mansur, Helder Nakaya, Leo Riella, Graham Pawelec and Steve Hedrick for critical readings of this manuscript. Finally, we wish to thank all the patients who accepted to enroll in the study and donate blood. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint 

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint B A . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint B A . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint Table 1 . Clinical characteristics of all patients in this study. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted April 16, 2021. ; https://doi.org/10.1101/2021.04.13.21255139 doi: medRxiv preprint

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

World Health Organization. WHO Coronavirus (COVID-19) Dashboard

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States

COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features

Multisystem Inflammatory Syndrome Related to COVID-19 in Previously Healthy Children and Adolescents

Lessons from COVID-19 in Children: Key Hypotheses to Guide Preventative and Therapeutic Strategies

Why is COVID-19 less severe in children? A review of the proposed mechanisms underlying the age-related difference in severity of SARS-CoV-2 antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum

Pre-existing and de novo humoral immunity to SARS-CoV-2 in humans

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals

Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Longitudinal analyses reveal immunological misfiring in severe COVID-19

Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19

WHO-2019-nCoV-Surveillance Case Definition-2020.2 eng

A serological assay to detect SARS-CoV-2 seroconversion in humans

Decisions about dendritic cells: Past, present, and future

HLA-DR Expression on Monocyte Subsets in Critically Ill Children

Indispensable role of CX3CR1+ dendritic cells in regulation of virus-induced neuroinflammation through rapid development of antiviral immunity in peripheral lymphoid tissues

CX3CR1-dependent endothelial margination modulates Ly6Chigh monocyte systemic deployment upon inflammation in mice

The M protein of SARS-CoV: basic structural and immunological properties

Proteins Is Not Associated with Recovery in Critical COVID-19 Patients